The adipose-derived hormone leptin maintains energy balance in part through central nervous system-mediated increases in sympathetic outflow that enhance fat burning. Triggering of b-adrenergic receptors in adipocytes stimulates energy expenditure by cyclic AMP (cAMP)-dependent increases in lipolysis and fatty-acid oxidation. Although the mechanism is unclear, catecholamine signalling is thought to be disrupted in obesity, leading to the development of insulin resistance. Here we show that the cAMP response element binding (CREB) coactivator Crtc3 promotes obesity by attenuating b-adrenergic receptor signalling in adipose tissue. Crtc3 was activated in response to catecholamine signals, when it reduced adenyl cyclase activity by upregulating the expression of Rgs2, a GTPase-activating protein that also inhibits adenyl cyclase activity. As a common human CRTC3 variant with increased transcriptional activity is associated with adiposity in two distinct Mexican-American cohorts, these results suggest that adipocyte CRTC3 may play a role in the development of obesity in humans.
Obesity is a major risk factor in the development of insulin resistance, which is characterized by decreased glucose uptake into muscle and increased glucose production by the liver. Obesity affects one-third of adults in the USA 1 ; the prevalence of obesity appears even higher in certain ethnic groups, although relevant predisposing factors have not been fully identified. Obesity is a particular problem among MexicanAmericans, with an overall prevalence of 40% (36% in men, 45% in women) 1 , contributing to elevated rates of diabetes 2 . Environment, lifestyle and genetic susceptibility probably contribute to the increased risk of obesity and diabetes in this population.
Under lean conditions, the adipose-derived hormone leptin is thought to promote energy expenditure through increases in sympathetic nerve activity that enhance catecholamine signalling in white adipose tissue (WAT) and brown adipose tissue (BAT) 3, 4 . Triggering of b-adrenergic receptors appears important for subsequent increases in lipolysis and fatty-acid oxidation 5 ; mice with knockouts of all three b receptors have reduced energy expenditure, and they are more susceptible to effects of high-fat diet (HFD) feeding on weight gain. Conversely, transgenic over-expression of b-adrenergic receptor 1 in adipose tissue appears sufficient to confer resistance to obesity 6 . Triggering of b-adrenergic receptors stimulates cAMP-mediated increases in cellular gene expression with burst-attenuation kinetics 7, 8 ; rates of transcription peak within 1 h of stimulation and decrease thereafter even under continuous stimulation. Although the underlying mechanisms remain unclear, the attenuation of cellular genes is thought to be coordinated by negative feedback effectors, which are themselves targets for upregulation by cAMP 9 . cAMP stimulates the expression of cellular genes through the protein kinase A (PKA)-mediated phosphorylation of CREB family members (CREB1, ATF1, CREM), a modification that promotes recruitment of the histone acetyl transferase paralogues P300 and CBP [10] [11] [12] .
In parallel, cAMP also increases gene expression by stimulating the CREB regulated transcriptional coactivators (CRTCs) 13, 14 . Under basal conditions, CRTCs are sequestered in the cytoplasm through phosphorylation-dependent interactions with 14-3-3 proteins. CRTCs are phosphorylated by salt-inducible kinases and other members of the stress-and energy-sensing AMPK family of Ser/Thr kinases. Increases in intracellular cAMP signalling promote the PKA-mediated phosphorylation and inhibition of salt-inducible kinase activity, leading to the subsequent dephosphorylation and nuclear entry of CRTCs, which bind to CREB over relevant promoters. After prolonged stimulation with cAMP agonist, CRTC activity is terminated through ubiquitin-mediated degradation 15 . The CRTC family consists of three members (Crtc1, Crtc2 and Crtc3), which are distinguished in part by their expression profiles. Crtc1 is produced primarily in brain, where it mediates leptin effects on satiety 16 ; mice with a knockout of the Crtc1 gene develop obesity due in part to reductions in energy expenditure. By contrast, Crtc2 is expressed at high levels in liver where it promotes fasting gluconeogenesis 17, 18 ; mice with a knockout of Crtc2 appear more insulin sensitive under HFD conditions, owing to reductions in hepatic glucose output 19 .
Role of CRTC3 as a CREB coactivator
Similar to other CRTC family members, Crtc3 contains CREB binding (CBD; amino acids 1-50), regulatory (RD; amino acids 51-549) and trans-activation domains (TAD; amino acids 550-619), which are also present in Crtc1 and Crtc2 (Fig. 1a) . In the basal state, Crtc3 is phosphorylated at Ser 162 by salt-inducible kinases and other members of the stress-and energy-sensing AMPK family of Ser/Thr kinases 13, 20, 21 . Short-term (0.5-1 h) exposure to cAMP agonist promotes the dephosphorylation and nuclear entry of Crtc3 (Fig. 1a) ; similar to Crtc2 15 , prolonged cAMP stimulation triggers Crtc3 degradation.
Crtc3 over-expression augments the activity of a cAMP responsive (CRE-luc) reporter in cells exposed to forskolin (FSK ; Fig. 1b) ; and mutation of the regulatory Ser162 phosphorylation site to alanine further enhances Crtc3 activity under basal conditions. In keeping with the proposed role of CREB in recruiting CRTC3 to relevant promoters, expression of a dominant negative CREB inhibitor, called ACREB 22 , blocks Crtc3 effects on reporter activity in cells exposed to FSK. By contrast with Crtc1, which is expressed primarily in brain, Crtc3 protein and messenger RNA (mRNA) amounts are particularly abundant in WAT and to a lesser extent in BAT ( Supplementary Fig. 1 and Fig. 1c) . 
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Based on the importance of the CBD for Crtc-mediated induction of cAMP-responsive genes 23, 24 , we generated Crtc3 2/2 mice with a deletion of exon 1, which encodes the CBD (Fig. 1d) . Crtc3 2/2 mice are born at the expected Mendelian frequency; they appear comparable to wild-type littermates at birth, despite the absence of detectable Crtc3 mRNA and protein amounts in all tissues (Fig. 1c) .
Role of CRTC3 in energy balance
When maintained on a normal chow diet, Crtc3 2/2 mice appear more insulin sensitive than controls by insulin tolerance testing (Supplementary Fig. 1, right) . Crtc3 2/2 animals also have 50% lower adipose tissue mass, despite comparable food intake and physical activity to control mice ( Supplementary Fig. 2) .
When transferred to an HFD (60% of calories from fat), Crtc3 2/2 mice gained 35% less weight relative to controls reflecting primarily differences in fat accumulation (Fig. 1e, f) . The effect of Crtc3 on adiposity appeared to be dependent on gene dosage as Crtc3 1/2 mice show intermediate weight gains relative to wild-type and Crtc3 2/2 mice. Although physical activity and food intake were nearly identical, energy expenditure and oxygen consumption were substantially elevated in HFD-fed Crtc3 2/2 mice relative to wild-type littermates (Fig. 2a, b) . Pointing to parallel increases in glucose and lipid oxidation, respiratory quotients were comparable in wild-type and Crtc3 2/2 mice ( Supplementary Fig.3 ). Circulating concentrations of free fatty acids were decreased in Crtc3 2/2 mice, and they were protected from the effects of HFD feeding on hepatic steatosis (Fig. 2c) . Consistent with their reduced fat mass, Crtc3 2/2 mice had decreased circulating leptin concentrations compared with wild-type littermates, although the reduction in leptin levels (tenfold) appeared disproportionately low relative to the difference in fat mass (threefold) ( Fig. 2d and Supplementary Fig. 4 ). Indeed, intraperitoneal administration of leptin stimulated energy expenditure to a greater extent in Crtc3 mutant than wild-type mice. Taken together, these results indicate that disruption of Crtc3 activity leads to increases in energy expenditure, which maintain leptin sensitivity and protect against ectopic lipid accumulation.
Under obese conditions, increases in inflammatory infiltrates in adipose tissue contribute to the development of systemic insulin resistance 25 . Although they were readily observed in wild-type mice, adipose-tissue macrophages were less abundant in Crtc3 2/2 tissue ( Fig. 2e and Supplementary Fig. 5 ). Arguing against an effect of the Crtc3 knockout on macrophage function per se, tumour necrosis factor-a release from peritoneal macrophages in response to lipopolysaccharide appeared comparable between Crtc3 mutant and control cells ( Supplementary Fig. 5 ). In line with these differences, circulating insulin concentrations were lower in HFD-fed Crtc3 2/2 than wildtype mice, and whole-body insulin sensitivity was correspondingly improved by insulin and glucose tolerance testing (Fig. 2f) . As a result, glucose uptake into muscle was increased in Crtc3 2/2 mice compared with control littermates (Supplementary Fig. 6 ).
We considered that Crtc3 activity in adipose tissue may be modulated by hormonal signals. In line with its effects on Crtc3 dephosphorylation in cell cultures ( Supplementary Fig. 7 ), intraperitoneal administration of b-adrenergic agonist isoproterenol (ISO) increased the activity of a CRE-luc reporter transgene in WAT and BAT by live imaging analysis (Fig. 3a) . Leptin administration (intraperitoneal) also promoted Crtc3 dephosphorylation. Crtc3 protein amounts in WAT are elevated under ad libitum conditions; they decreased after fasting for 6 , when Crtc3 appeared to undergo degradation (Fig. 3a) . Consistent with an increase in protein stability under obese conditions, Creb and Crtc3 protein amounts were upregulated in WAT from HFD-fed mice compared with those fed on normal chow ( Supplementary Fig. 8 ). 2/2 mice. a, b, Energy expenditure and oxygen consumption (a) as well as food intake and physical activity (b) in HFD-fed mice (n54 per group). c, Free-fatty-acid levels (top) and haematoxylin and eosin sections of livers (bottom) in HFD-fed mice (n53 per group) (**P,0.01). d, Leptin levels (top) (n55 per group) and effect of intraperitoneal leptin administration on energy expenditure (bottom) (n54 per group) (*P,0.05; ***P,0.001). e, Macrophage infiltration (top) and gene expression (bottom) in WAT from HFD-fed mice. Scale bar, 50 mm. f, Insulin levels (top), insulin tolerance testing (middle) and glucose tolerance testing (bottom) of HFD-fed mice (n55 per group) (*P,0.05; **P,0.01; ***P,0.001). Error bars, s.e.m.
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Catecholamine signalling in adipose tissue
Under HFD feeding conditions, increases in catecholamine signalling maintain energy balance by mobilizing triglyceride stores in WAT 26 . Although the total number of adipocytes in WAT fat pads was nearly identical in both groups, adipocytes from Crtc3 2/2 mice were substantially smaller than from wild-type mice (Fig. 3b) . Arguing against a disruption in triglyceride synthesis, mRNA amounts for lipogenic genes (Acc, Lpl, Scd) appeared comparable between Crtc3 mutant and wild-type adipocytes (Supplementary Fig. 9 ). Rather, basal and ISOinduced lipolysis rates were increased in Crtc3 2/2 compared with control adipocytes (Fig. 3c ). Exposure to FSK also increased lipolysis to a greater extent in Crtc3 2/2 adipocytes (Fig. 3c) , pointing to the potential upregulation of the cAMP signalling pathway in these cells.
Triggering of b-adrenergic receptors has been found to promote lipolysis through the cAMP-dependent PKA-mediated phosphorylation of hormone sensitive lipase (HSL) 27 . In keeping with the proposed downregulation of b-adrenergic receptor signalling in obesity, administration of ISO had only modest effects on HSL phosphorylation in HFD-fed relative to animals fed on normal chow (Fig. 3d) . Indeed, amounts of phospho-(Ser 660) HSL were substantially elevated 
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2/2 WAT compared with wild type, even though circulating concentrations of noradrenaline and adrenaline were similar between the two groups (Fig 3d and Supplementary Fig. 10 ). PKA activity in WAT was also increased in Crtc3 2/2 mice by immunoblot assay using a phospho-specific PKA substrate antiserum (Fig. 3d) . Consistent with the predominant expression of Crtc3 in adipose tissue, PKA activity in other tissues appeared similar between wild-type and Crtc3 2/2 mice ( Supplementary Fig. 11 ).
Having seen that lipolysis rates are increased in WAT, and realizing that circulating free-fatty-acid concentrations are reduced in Crtc3 mutant mice, we considered that fatty-acid oxidation should also be upregulated in this setting. Under HFD conditions, leptin has been proposed to trigger catecholamine-mediated increases in fat burning in BAT, a process known as diet-induced thermogenesis 28, 29 . In keeping with the ability for catecholamines to stimulate BAT expansion, brown adipocyte numbers were increased twofold in intra-scapular fat pads from Crtc3 2/2 mice compared with controls (Fig. 3e) . Suggesting a parallel increase in fat burning, Crtc3 2/2 brown adipocytes also had smaller intracellular lipid vacuoles than wild-type cells. Moreover, fatty-acid oxidation rates were increased in primary brown adipocytes from Crtc3 2/2 mice relative to controls, and uncoupling protein 1 (Ucp1) mRNA amounts were also higher (Fig. 3f) . Correspondingly, core body temperatures were elevated in Crtc3 2/2 mice compared with control animals. Taken together, these results indicate that loss of Crtc3 increases fat burning in part through increases in brown adipocyte numbers in BAT.
We reasoned that the loss of Crtc3 expression could increase cellular PKA activity by altering the subunit composition of the PKA holoenzyme. Over-expression of the forkhead protein Foxc2 in WAT, for example, has been found to promote energy expenditure by upregulating mRNA amounts for regulatory subunit I, which has a higher affinity for cAMP than RII 30 . Arguing against this possibility, however, mRNA amounts for regulatory subunits I and II in WAT were comparable between wild type and Crtc3 mutants ( Supplementary Fig. 12, left) .
cAMP accumulation in CRTC3 mutant cells
Alternatively, disruption of the Crtc3 gene may enhance PKA activity by increasing cellular cAMP accumulation in response to hormonal signals. Supporting this idea, cAMP concentrations were elevated in WAT from Crtc3 mutant mice relative to controls (Fig. 4a) . Exposure to FSK also triggered cAMP accumulation to a greater extent in Crtc3 2/2 mouse embryonic fibroblasts (MEFs) and in Crtc3
BAT stromal-vascular cells compared with wild-type cells ( Fig. 4a and Supplementary Fig. 12 , right). Moreover, Crtc3 over-expression in wild-type cells reduced cAMP production in response to FSK, whereas acute RNA interference (RNAi)-mediated depletion of Crtc3 increased it ( Fig. 4b and Supplementary Fig. 13 ). In principle, the enhanced accumulation of cAMP in Crtc3-deficient cells could reflect a decrease in cellular phosphodiesterase activity. In that event, treatment with non-selective phosphodiesterase inhibitor should lead to comparable increases in cAMP concentrations between wild-type and mutant cells exposed to b-adrenergic agonist. However, intracellular cAMP concentrations remained higher in Crtc3 2/2 than wild-type cells after co-stimulation with ISO plus isobutyl-methyl xanthine ( Supplementary Fig. 14) . Based on these results, we reasoned that Crtc3 probably inhibits cAMP signalling by modulating cellular adenyl cyclase activity.
In gene profiling studies to identify cellular genes that mediate inhibitory effects of Crtc3 on cAMP signalling, we identified the Regulator of G protein signalling 2 (Rgs2) as the most highly upregulated gene of 15 that are induced threefold or better in adipocytes exposed to FSK 31 . We confirmed these effects in cultured primary 
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adipocytes, where exposure to FSK increased the expression of Rgs2 and other targets in wild-type cells, but to a much lesser extent in Crtc3 2/2 cells (Fig. 4c , top, and Supplementary Fig. 15 ). By contrast with its reduction in adipose tissue from Crtc3 2/2 mice, Creb target gene expression in skeletal muscle appeared comparable between wild-type and Crtc3 mutant animals, probably reflecting regulatory contributions from Crtc2, which has been shown to promote the expression of PGC-1a and mitochondrial genes in muscle cells 32 . First identified as a GTPase activating protein that blocks Gq signalling, Rgs2 has also been shown to inhibit the cAMP pathway by binding directly to a subset of adenyl cyclases (types III, V and VI) [33] [34] [35] , isoforms that are enriched in BAT and WAT 36, 37 . Moreover, mutations that enhance RGS2 expression have been associated with increased risk of metabolic syndrome in humans 38 . In keeping with the upregulation of Crtc3 in obesity, HFD feeding stimulated Rgs2 mRNA amounts in wild-type WAT, but Rgs2 expression remained low in WAT from HFD-fed Crtc3 2/2 mice (Fig. 4c, bottom) . Consistent with its proposed role as an adenyl cyclase inhibitor, Rgs2 over-expression reduced cAMP production in cells exposed to FSK, whereas RNAi-mediated knockdown of Rgs2 increased it ( Fig. 4d and Supplementary Figs 16 and 17) .
We examined whether the Rgs2 gene is a direct target of Creb and Crtc3. In line with the presence of conserved CREB binding sites at 2184 and 266 on the Rgs2 promoter, exposure to FSK upregulated RGS2-luciferase reporter activity in transient transfection assays (Fig. 4e) . Crtc3 over-expression further enhanced RGS2 promoter activity, whereas RNAi-mediated depletion of Crtc3 reduced it. Consistent with a direct effect of these activators, exposure to FSK increased Creb and Crtc3 occupancy over the RGS2 promoter in wild-type cells (Fig. 4e) .
Role of CRTC3 in human obesity
Having seen the effects of Crtc3 on energy expenditure, we wondered whether this coactivator also contributes to obesity in humans. Within the human database of single nucleotide polymorphisms (dbSNP), we noticed a common CRTC3 variant allele, which encodes a missense variant (S72N) near a predicted nuclear export sequence 39 . Supporting this idea, nuclear amounts of 72N CRTC3 were elevated relative to 72S CRTC3 under basal conditions (Fig. 4f) . Correspondingly, 72N variant CRTC3 was more potent than 72S CRTC3 in stimulating RGS2 promoter activity, particularly under basal conditions (Fig. 4f) .
We examined the potential association between the S72N variant CRTC3 and adiposity in a Mexican-American cohort of 779 individuals ( Table 1 ). The allele frequency of the 72N variant in this population was 34%. In keeping with its increased activity relative to wild-type CRTC3, the 72N allele was also associated with several anthropometric indices of adiposity including weight, body mass index (BMI) and hip circumference. Similar to the gene dosage effect of CRTC3 on weight gain in mice, Mexican-Americans with two 72N alleles had increased adiposity compared with those with only one variant allele; and 72S/72N heterozygous individuals had intermediate adiposity relative to individuals homozygous for the wild-type and variant CRTC3 alleles.
We then sought to confirm the association of 72N with increases in adiposity indices, by assessing the association of a perfect proxy SNP rs3862434 (r 2 51 with S72N) with adiposity measures in 987 Mexican-Americans from the Multi-Ethnic Study of Atherosclerosis (MESA). The minor allele of rs3862434 (G, frequency 34%), which corresponds to 72N, was associated with increased body surface area (BSA) and a trend to increased weight (Supplementary Table 1 ). In an analysis combining the two cohorts, 72N exhibited associations with weight, hip circumference, BMI and BSA (Supplementary Table 2 ). Because these traits are interrelated, we did not use multiple testing correction, which would be overly conservative because our other data suggested 72N altered the biological function of CRTC3. Taken together, these results indicate that CRTC3 is associated with increased obesity risk in Mexican-Americans.
This association did not extend to 2,527 non-Hispanic whites from MESA, in whom we observed no association of rs3862434 with any of the six available obesity traits (Supplementary Table 3 ). Of note, the G allele of rs3862434 (proxy for the adiposity-associated 72N allele) is the minor allele in Mexican-Americans and the major allele in nonHispanic whites. We then conducted a z-score meta-analysis in over 63,000 subjects from the Cohorts for Heart and Aging Research in Genome Epidemiology (CHARGE) and Genetic Investigation of ANthropometric Traits (GIANT) consortia, examining the association of S72N with BMI. In this meta-analysis, the 72N allele was associated with increased BMI; however, this did not reach statistical significance (z-score 0.74, P50.45). This suggests that the effect of 72N to promote obesity, although substantial in Mexican-Americans, is very weak or non-existent in non-Hispanic whites. As the 72N allele is more frequent in non-Hispanic whites, and yet has a minimal effect on BMI in this population, our results are consistent with the observation that obesity is less frequent in non-Hispanic whites than Mexican-Americans 1 . The weaker effect of 72N in non-Hispanic whites may be due to environmental/lifestyle factors and/or differences in genetic background.
Discussion
HFD feeding has been shown to promote obesity and insulin resistance through increases in energy intake that lead to the ectopic deposition of lipid in liver. Our results suggest that Crtc3 contributes to these changes in part by attenuating catecholamine signalling in adipose tissue ( Supplementary Fig. 18 ).
Although the proposed role of Crtc3 as a negative feedback regulator of adipocyte cAMP signalling was unexpected, we note that intracellular signalling pathways often self-attenuate as part of a homeostatic mechanism to limit cellular responses to hormonal stimuli 7 . Thus the chronic upregulation of sympathetic nerve activity under HFD conditions 26 may attenuate the intracellular cAMP pathway through the Crtc3-mediated induction of Rgs2. By limiting catecholamine-dependent increases in lipolysis and fatty-acid oxidation, Crtc3 may also function as a so-called 'thrifty' gene that enhances survival under starvation conditions. Future studies may reveal the extent to which CRTC3 also contributes to the development of insulin resistance and type II diabetes.
METHODS SUMMARY
Crtc3
2/2 mice were generated by targeted disruption of exon 1 in the Crtc3
gene, which encodes the CREB binding domain. Transgenic CRE-luciferase reporter mice were generated and analysed by in vivo imaging with an IVIS-100 instrument (Caliper Life Sciences). For indirect calorimetry studies, mice were housed individually; oxygen consumption and energy expenditure were measured using a LabMaster system (TSE Systems). Circulating leptin, insulin and free-fatty-acid concentrations were measured by enzyme-linked immunosorbent assay (ELISA). In vitro lipolysis and fatty oxidation rates were evaluated on cultures of primary white and brown adipocytes as described 31, 40 ; glucose uptake was measured in soleus muscle using [U- 14 C]2-deoxyglucose. PKA activity was examined in different tissues by immunoblot assay with phospho-PKA substrate antiserum (Cell Signaling). Intracellular cAMP accumulation in wildtype and CRTC3 mutant cells was measured by ELISA. Crtc3 and Creb occupancies over cellular genes were evaluated by chromatin immunoprecipitation assay 13 . For studies of human genetic association, that of CRTC3 variant (S72N) with 
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adiposity parameters was assessed in participants of the Cedars-Sinai/University of California, Los Angeles, Mexican-American Coronary Artery Disease (MACAD) study, comprising 779 subjects 41, 42 . Confirmatory studies were performed on Mexican-American subjects from the Multi-Ethnic Study of Atherosclerosis (MESA) 43 , containing 987 Mexican-American individuals. Genotyping of SNP rs8033595 (S72N) in MACAD was performed using TaqManMGB technology 42, 44 . This SNP was also explored for association with body mass index in the CHARGE and GIANT consortia. To obtain a replication cohort most similar to that of MACAD, we studied MESA Hispanics with exclusion of those recruited from the New York site, as the latter are mainly from the Caribbean and may thus have genetic differences from the Mexican-Americans of MACAD 45 . This resulted in a cohort of 987 MESA Mexican-Americans.
To determine whether the genetic associations observed in MexicanAmericans would also be seen in other ethnic groups, we also examined 2,527 non-Hispanic white subjects from MESA who had available anthropometric data. We then also accessed data from two large consortia of non-Hispanic whites, CHARGE (n 5 31,373) 46 and GIANT (n 5 32,504) 47 , both of which had conducted genome-wide association studies of BMI. These datasets did not overlap in subjects. Genotyping of human samples. Genotyping of SNP rs8033595 (S72N) in MACAD was performed using TaqMan MGB technology as previously described 42, 44 . The genotyping success rate was 98.3%. In the MESA Mexican-American and white cohorts, S72N was represented by a proxy SNP rs3862434 (A/G, r 2 51 with S72N in the Mexican-American cohort of the phase III HapMap data, and r 2 51 in the Caucasian European cohort of the phase II HapMap) that was directly genotyped (not imputed) in the genome-wide association study conducted in MESA. In CHARGE and GIANT, rs8033595 was either directly genotyped or imputed, depending on the genome-wide association study arrays used in the individual cohorts comprising each consortium. Human genetic association analysis. The MACAD cohort is composed of small families and marrying-in spouses. Therefore the generalized estimating equation RESEARCH ARTICLE
